Consistently, presentation of the OVA tumor antigen was enhanced by TET2 following IFN-γ stimulation, which was further stimulated by VC treatment, and effective in vitro cytotoxic activity of T cells requires TET2 tumor expression. This evidence concerns the gene TET2 and neoplasm.